Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 15/02/2012
PIL Seroquel XL 50mg, 150mg, 200mg, 300mg, 400mg prolonged-release tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 24/08/2011 and displayed until 15/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 16/03/2011 and displayed until 24/08/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 23/09/2010 and displayed until 16/03/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
Updated on 17/02/2010 and displayed until 23/09/2010
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 14/10/2009 and displayed until 17/02/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 20/04/2009 and displayed until 14/10/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 19/09/2008 and displayed until 20/04/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  quetiapine fumarate